iMed.ULisboa investigator awarded with the Grant for Multiple Sclerosis Innovation (GMSI) 2017
Adelaide Fernandes, researcher of the Neuron-Glia Biology in Health and Disease group at iMed.ULisboa was awarded during the 2017 ECTRIMS conference, Paris, 24-28 October, 2017, with the Grant for Multiple Sclerosis Innovation (GMSI) 2017, funded by Merck/EMD Serono. The interdisciplinary project entitled “Targeting multiple sclerosis immune- and psycho-pathophysiology by modulation of neuroinflammation” will be developed in close collaboration with the clinician João Cerqueira (Clinical Director of the Multiple Sclerosis clinic at the Hospital de Braga, Researcher at the ICVS/3B’s, University of Minho, and president of the Grupo de Estudos de Esclerose Múltipla, GEEM).
The objective of this project is to use a holistic approach, looking at both Multiple Sclerosis patient and animal model data, to clarify how the presence of neuroinflammation may be involved in the emergence of the psychopathological symptoms in Multiple Sclerosis patients and whether we may prevent them by targeting specific inflammatory molecules. The ultimate goal is to translate the results of the project to the benefit of patients using a personalised medicine to reduce both Multiple Sclerosis-related central nervous system damage and psychiatric comorbidity.